NIDA 41020 |
| Katalog-Nr.GC13267 |
NIDA 41020 ist ein potenter und selektiver Cannabinoid-Rezeptor-1(CB1)-Antagonist mit einem Ki von 4,1 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 502486-89-7
Sample solution is provided at 25 µL, 10mM.
GlpBio Produkte in seriösen Veröffentlichungen zitiert
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 502486-89-7 | SDF | |
| Chemical Name | 1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide | ||
| Canonical SMILES | ClC1=CC(Cl)=CC=C1N2N=C(C(C)=C2C(C=C3)=CC=C3OC)C(NN4CCCCC4)=O | ||
| Formula | C23H24Cl2N4O2 | M.Wt | 459.37 |
| Löslichkeit | DMSO: <100mM,Ethanol: <100mM | Storage | Store at RT |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.1769 mL | 10.8845 mL | 21.7689 mL |
| 5 mM | 0.4354 mL | 2.1769 mL | 4.3538 mL |
| 10 mM | 0.2177 mL | 1.0884 mL | 2.1769 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC18902 Heronamide C
- GC41803 1,2-Dimyristoyl-sn-glycero-3-PC
- GC61603 Fmoc-aminooxy-PEG2-NH2
- GC17215 Elacridar
- GC50109 AZD 5582 dihydrochloride
- GC16547 ICI 215,001 hydrochloride
- GC61121 Neopuerarin A
- GC10586 Sulfamerazine
- GC35654 Ceratamine A
- GC19032 AVex-73 hydrochloride
- GC17416 ACHP
- GC13752 Hexanolamino PAF C-16
- GC34470 AMXT-1501 tetrahydrochloride
- GC32879 PF-06840003 (EOS200271)
- GC45746 8(R),11(S)-DiHODE
- GC18553 CCK (26-31) (sulfated)
- GC42736 ADP-Glucose (sodium salt)
Bewertungen
Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *